The basaloid-spectrum of salivary gland tumors: A focused review with practical diagnostic considerations

Semin Diagn Pathol. 2024 Jul;41(4):173-181. doi: 10.1053/j.semdp.2024.06.003. Epub 2024 Jun 13.

Abstract

Basaloid salivary gland neoplasms are a diverse and varied group of benign and malignant tumors. The term 'basaloid' is broadly used in reference to cells with elevated nuclear to cytoplasmic ratio, sparse cytoplasm, and hyperchromatic nuclei. However, a subset may also fit within the "small round blue cell tumor" morphologic category or the "biphasic" salivary gland tumor category. Furthermore, there are no established thresholds for the proportion of basaloid tumor cells needed to consider a tumor within the basaloid spectrum. Given the implicit variability in what is considered a basaloid salivary gland tumor, one may question the inclusion of certain entities (canalicular adenoma, HMGA2::WIF1 pleomorphic adenoma, polymorphous adenocarcinoma) in this review based on classic morphologic features. However, salivary gland tumors with even minor basaloid components may appear 'basaloid' in small biopsy specimens and, thus, a choice was made to focus on common and uncommon diagnostic differentials with this in mind. Entities that will be covered in this review also include basal cell adenoma and basal cell adenocarcinoma, adenoid cystic carcinoma, lymphoepithelial carcinoma, sialoblastoma, adamantinoma-like Ewing Sarcoma, NUT carcinoma, and carcinoma showing thymus-like differentiation.

Keywords: Basaloid; Neoplasm; Salivary gland.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / analysis
  • Diagnosis, Differential
  • Humans
  • Salivary Gland Neoplasms* / diagnosis
  • Salivary Gland Neoplasms* / pathology

Substances

  • Biomarkers, Tumor